Pascal Soriot spoke exclusively with CNBC from the site of AstraZeneca's new $1 billion R&D facility in Kendall Square in Cambridge, Massachusetts.
CNBC’s Annika Kim Constantino and Pascal Soriot, AstraZeneca CEO, join 'The Exchange' to discuss its $50 billion investment in stateside manufacturing and opening an research and development site in ...
AstraZeneca is readying to file the first of a new portfolio of targeted cancer drugs for regulatory approval, moving to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results